Helix Biopharma Corp About
Helix Helix BioPharma Corp. is a biopharmaceutical company
focused on the development and commercialization of innovative cancer therapeutics.
Helix's business model is to commercialize the new products that result from our
development efforts by establishing strategic licensing arrangements with market
leaders in the appropriate therapeutic fields. Helix’s product development
initiatives are based on its proprietary core technologies. These include the
Biphasix™
drug delivery technology, the Heterodimer
Protein Technology and the Targeted
Catabolic Amplification Technology (TCAT). CLINICAL DEVELOPMENT -- Topical
Interferon Alpha-2b for for ano-genital human papilloma virus (HPV) infections. More
on
Helix Biopharma Corp Key
Statistics for Helix Biopharma
Basic
Chart for Helix Biopharma